{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:49:09Z","timestamp":1768542549073,"version":"3.49.0"},"reference-count":46,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRP"],"published-print":{"date-parts":[[2021,3,31]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> To compare visual and semi-quantitative analysis of brain [<jats:sup>18<\/jats:sup>F]Florbetaben\nPET images in Mild Cognitive Impairment (MCI) patients and relate this finding to the degree\nof \u00df-amyloid burden.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A sample of 71 amnestic MCI patients (age 74 \u00b1 7.3 years, Mini Mental State Examination\n24.2 \u00b1 5.3) underwent cerebral [<jats:sup>18<\/jats:sup>F]Florbetaben PET\/CT. Images were visually scored as positive\nor negative independently by three certified readers blinded to clinical and neuropsychological\nassessment. Amyloid positivity was also assessed by semiquantitative approach by means of a previously\npublished threshold (SUVr \u2265 1.3). Fleiss kappa coefficient was used to compare visual analysis\n(after consensus among readers) and semi-quantitative analysis. Statistical significance was\ntaken at P&lt;0.05.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>After the consensus reading, 43\/71 (60.6%) patients were considered positive. Cases that\nwere interpreted as visually positive had higher SUVr than visually negative patients (1.48 \u00b1 0.19\nvs 1.11 \u00b1 0.09) (P&lt;0.05). Agreement between visual analysis and semi-quantitative analysis was excellent\n(k=0.86, P&lt;0.05). Disagreement occurred in 7\/71 patients (9.9%) (6 false positives and 1\nfalse negative). Agreement between the two analyses was 90.0% (18\/20) for SUVr &lt; 1.1, 83%\n(24\/29) for SUVr between 1.1 and 1.5, and 100% (22\/22) for SUVr &gt; 1.5 indicating lowest agreement\nfor the group with intermediate amyloid burden.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Inter-rater agreement of visual analysis of amyloid PET images is high. Agreement between\nvisual analysis and SUVr semi-quantitative analysis decreases in the range of 1.1&lt;SUVr\n&lt;=1.5, where the clinical scenario is more challenging.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874471013666200729155717","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T08:06:16Z","timestamp":1596960376000},"page":"70-77","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Tracer Retention Levels on Visual Analysis of Cerebral [18F]- Florbetaben Pet Images"],"prefix":"10.2174","volume":"14","author":[{"given":"Giampiero","family":"Giovacchini","sequence":"first","affiliation":[{"name":"Nuclear Medicine Unit S. Andrea Hospital Via Vittorio Veneto, 197 19124 La Spezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Giovannini","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit S. Andrea Hospital Via Vittorio Veneto, 197 19124 La Spezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Bors\u00f2","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit S. Andrea Hospital Via Vittorio Veneto, 197 19124 La Spezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Lazzeri","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit S. Andrea Hospital Via Vittorio Veneto, 197 19124 La Spezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Duce","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit S. Andrea Hospital Via Vittorio Veneto, 197 19124 La Spezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ornella","family":"Ferrando","sequence":"additional","affiliation":[{"name":"Medical Physics Unit, S. Andrea Hospital, La Spezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franca","family":"Foppiano","sequence":"additional","affiliation":[{"name":"Medical Physics Unit, S. Andrea Hospital, La Spezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6579-656X","authenticated-orcid":true,"given":"Andrea","family":"Ciarmiello","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit S. Andrea Hospital Via Vittorio Veneto, 197 19124 La Spezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.nicl.2015.10.007","volume":"9","author":"Mountz J.M.","year":"2015","unstructured":"Mountz J.M.; Laymon C.M.; Cohen A.D.; Zhang Z.; Price J.C.; Boudhar S.; McDade E.; Aizenstein H.J.; Klunk W.E.; Mathis C.A.; Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer\u2019s subjects. Neuroimage Clin 2015,9,592-598","journal-title":"Neuroimage Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"Mirra S.S.","year":"1991","unstructured":"Mirra S.S.; Heyman A.; McKeel D.; Sumi S.M.; Crain B.J.; Brownlee L.M.; Vogel F.S.; Hughes J.P.; van Belle G.; Berg L.; The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 1991,41(4),479-486","journal-title":"Neurology"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005072-199710000-00002","volume":"56","author":"Hyman B.T.","year":"1997","unstructured":"Hyman B.T.; Trojanowski J.Q.; Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997,56(10),1095-1097","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"Klunk W.E.","year":"2004","unstructured":"Klunk W.E.; Engler H.; Nordberg A.; Wang Y.; Blomqvist G.; Holt D.P.; Bergstr\u00f6m M.; Savitcheva I.; Huang G.F.; Estrada S.; Aus\u00e9n B.; Debnath M.L.; Barletta J.; Price J.C.; Sandell J.; Lopresti B.J.; Wall A.; Koivisto P.; Antoni G.; Mathis C.A.; L\u00e5ngstr\u00f6m B.; Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol 2004,55(3),306-319","journal-title":"Ann Neurol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.2174\/1381612043384772","volume":"10","author":"Mathis C.A.","year":"2004","unstructured":"Mathis C.A.; Wang Y.; Klunk W.E.; Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain. Curr Pharm Des 2004,10(13),1469-1492","journal-title":"Curr Pharm Des"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40336-015-0102-6","volume":"3","author":"Sabri O.","year":"2015","unstructured":"Sabri O.; Seibyl J.; Rowe C.; Barthel H.; Beta-amyloid imaging with florbetaben. Clin Transl Imaging 2015,3(1),13-26","journal-title":"Clin Transl Imaging"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaneurol.2014.4144","volume":"72","author":"Curtis C.","year":"2015","unstructured":"Curtis C.; Gamez J.E.; Singh U.; Sadowsky C.H.; Villena T.; Sabbagh M.N.; Beach T.G.; Duara R.; Fleisher A.S.; Frey K.A.; Walker Z.; Hunjan A.; Holmes C.; Escovar Y.M.; Vera C.X.; Agronin M.E.; Ross J.; Bozoki A.; Akinola M.; Shi J.; Vandenberghe R.; Ikonomovic M.D.; Sherwin P.F.; Grachev I.D.; Farrar G.; Smith A.P.; Buckley C.J.; McLain R.; Salloway S.; Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density. JAMA Neurol 2015,72(3),287-294","journal-title":"JAMA Neurol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1056\/NEJMp1208061","volume":"367","author":"Yang L.","year":"2012","unstructured":"Yang L.; Rieves D.; Ganley C.; Brain amyloid imaging--FDA approval of florbetapir F18 injection. N Engl J Med 2012,367(10),885-887","journal-title":"N Engl J Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","volume":"25","author":"Price J.C.","year":"2005","unstructured":"Price J.C.; Klunk W.E.; Lopresti B.J.; Lu X.; Hoge J.A.; Ziolko S.K.; Holt D.P.; Meltzer C.C.; DeKosky S.T.; Mathis C.A.; Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab 2005,25(11),1528-1547","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2967\/jnumed.113.133793","volume":"55","author":"Ito H.","year":"2014","unstructured":"Ito H.; Shimada H.; Shinotoh H.; Takano H.; Sasaki T.; Nogami T.; Suzuki M.; Nagashima T.; Takahata K.; Seki C.; Kodaka F.; Eguchi Y.; Fujiwara H.; Kimura Y.; Hirano S.; Ikoma Y.; Higuchi M.; Kawamura K.; Fukumura T.; B\u00f6\u00f6 E.L.; Farde L.; Suhara T.; Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer \u00b9\u00b9C-AZD2184. J Nucl Med 2014,55(6),932-938","journal-title":"J Nucl Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00259-013-2564-y","volume":"41","author":"Hatashita S.","year":"2014","unstructured":"Hatashita S.; Yamasaki H.; Suzuki Y.; Tanaka K.; Wakebe D.; Hayakawa H.; [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 2014,41(2),290-300","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2967\/jnumed.106.037762","volume":"48","author":"Ng S.","year":"2007","unstructured":"Ng S.; Villemagne V.L.; Berlangieri S.; Lee S.T.; Cherk M.; Gong S.J.; Ackermann U.; Saunder T.; Tochon-Danguy H.; Jones G.; Smith C.; O\u2019Keefe G.; Masters C.L.; Rowe C.C.; Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer\u2019s disease. J Nucl Med 2007,48(4),547-552","journal-title":"J Nucl Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.neuroimage.2010.12.070","volume":"55","author":"Rosario B.L.","year":"2011","unstructured":"Rosario B.L.; Weissfeld L.A.; Laymon C.M.; Mathis C.A.; Klunk W.E.; Berginc M.D.; James J.A.; Hoge J.A.; Price J.C.; Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET. Neuroimage 2011,55(3),933-941","journal-title":"Neuroimage"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00259-018-4149-2","volume":"46","author":"Ciarmiello A.","year":"2019","unstructured":"Ciarmiello A.; Tartaglione A.; Giovannini E.; Riondato M.; Giovacchini G.; Ferrando O.; De Biasi M.; Passera C.; Carabelli E.; Mannironi A.; Foppiano F.; Alfano B.; Mansi L.; Amyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer\u2019s disease in mild cognitive impairment patients. Eur J Nucl Med Mol Imaging 2019,46(2),288-296","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"Petersen R.C.","year":"1999","unstructured":"Petersen R.C.; Smith G.E.; Waring S.C.; Ivnik R.J.; Tangalos E.G.; Kokmen E.; Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999,56(3),303-308","journal-title":"Arch Neurol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","volume":"39","author":"Morris J.C.","year":"1989","unstructured":"Morris J.C.; Heyman A.; Mohs R.C.; Hughes J.P.; van Belle G.; Fillenbaum G.; Mellits E.D.; Clark C.; The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer\u2019s disease. Neurology 1989,39(9),1159-1165","journal-title":"Neurology"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"Rom\u00e1n G.C.","year":"1993","unstructured":"Rom\u00e1n G.C.; Tatemichi T.K.; Erkinjuntti T.; Cummings J.L.; Masdeu J.C.; Garcia J.H.; Amaducci L.; Orgogozo J.M.; Brun A.; Hofman A.; Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993,43(2),250-260","journal-title":"Neurology"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00259-012-2268-8","volume":"40","author":"Tiepolt S.","year":"2013","unstructured":"Tiepolt S.; Barthel H.; Butzke D.; Hesse S.; Patt M.; Gertz H.J.; Reininger C.; Sabri O.; Influence of scan duration on the accuracy of \u03b2-amyloid PET with florbetaben in patients with Alzheimer\u2019s disease and healthy volunteers. Eur J Nucl Med Mol Imaging 2013,40(2),238-244","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2967\/jnumed.112.107185","volume":"54","author":"Becker G.A.","year":"2013","unstructured":"Becker G.A.; Ichise M.; Barthel H.; Luthardt J.; Patt M.; Seese A.; Schultze-Mosgau M.; Rohde B.; Gertz H.J.; Reininger C.; Sabri O.; PET quantification of 18F-florbetaben binding to \u03b2-amyloid deposits in human brains. J Nucl Med 2013,54(5),723-731","journal-title":"J Nucl Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"900","DOI":"10.2967\/jnumed.115.161927","volume":"57","author":"Seibyl J.","year":"2016","unstructured":"Seibyl J.; Catafau A.M.; Barthel H.; Ishii K.; Rowe C.C.; Leverenz J.B.; Ghetti B.; Ironside J.W.; Takao M.; Akatsu H.; Murayama S.; Bullich S.; Mueller A.; Koglin N.; Schulz-Schaeffer W.J.; Hoffmann A.; Sabbagh M.N.; Stephens A.W.; Sabri O.; Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study. J Nucl Med 2016,57(6),900-906","journal-title":"J Nucl Med"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012883","volume":"11","author":"Mart\u00ednez G.","year":"2017","unstructured":"Mart\u00ednez G.; Vernooij R.W.; Fuentes Padilla P.; Zamora J.; Flicker L.; Bonfill Cosp X.; 18F PET with florbetaben for the early diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2017,11","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s00259-016-3591-2","volume":"44","author":"Yamane T.","year":"2017","unstructured":"Yamane T.; Ishii K.; Sakata M.; Ikari Y.; Nishio T.; Ishii K.; Kato T.; Ito K.; Senda M.; Inter-rater variability of visual interpretation and comparison with quantitative evaluation of C-PiB PET amyloid images of the Japanese Alzheimer\u2019s Disease Neuroimaging Initiative (J-ADNI) multicenter study. Eur J Nucl Med Mol Imaging J-ADNI Study Group2017,44(5),850-857","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/hbm.460020402","volume":"2","author":"Friston K.J.","year":"1994","unstructured":"Friston K.J.; Holmes A.P.; Worsley K.J.; Poline J.P.; Frith C.D.; Frackowiak R.S.J.; Statistical parametricmaps in functional imaging: a general linear approach. Hum Brain Mapp 1994,2,189-210","journal-title":"Hum Brain Mapp"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.532","volume":"6","author":"Sasaki K.","year":"2016","unstructured":"Sasaki K.; Maikusa N.; Imabayashi E.; Yuasa T.; Matsuda H.; The feasibility of C-PIB-PET\/CT for amyloid plaque burden: validation of the effectiveness of CT-based partial volume correction. Brain Behav 2016,6(10)","journal-title":"Brain Behav"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8","volume":"10","author":"Lancaster J.L.","year":"2000","unstructured":"Lancaster J.L.; Woldorff M.G.; Parsons L.M.; Liotti M.; Freitas C.S.; Rainey L.; Kochunov P.V.; Nickerson D.; Mikiten S.A.; Fox P.T.; Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 2000,10(3),120-131","journal-title":"Hum Brain Mapp"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"Braak H.","year":"1991","unstructured":"Braak H.; Braak E.; Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991,82(4),239-259","journal-title":"Acta Neuropathol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1093\/brain\/awt142","volume":"136","author":"Ni R.","year":"2013","unstructured":"Ni R.; Gillberg P.G.; Bergfors A.; Marutle A.; Nordberg A.; Amyloid tracers detect multiple binding sites in Alzheimer\u2019s disease brain tissue. Brain 2013,136(Pt 7),2217-2227","journal-title":"Brain"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","volume":"11","author":"Sabri O.","year":"2015","unstructured":"Sabri O.; Sabbagh M.N.; Seibyl J.; Barthel H.; Akatsu H.; Ouchi Y.; Senda K.; Murayama S.; Ishii K.; Takao M.; Beach T.G.; Rowe C.C.; Leverenz J.B.; Ghetti B.; Ironside J.W.; Catafau A.M.; Stephens A.W.; Mueller A.; Koglin N.; Hoffmann A.; Roth K.; Reininger C.; Schulz-Schaeffer W.J.; Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer\u2019s disease: phase 3 study. Alzheimers Dement Florbetaben Phase 3 Study Group2015,11(8),964-974","journal-title":"Alzheimers Dement"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2967\/jnumed.118.211532","volume":"60","author":"Collij L.E.","year":"2019","unstructured":"Collij L.E.; Konijnenberg E.; Reimand J.; Kate M.T.; Braber A.D.; Lopes Alves I.; Zwan M.; Yaqub M.; van Assema D.M.E.; Wink A.M.; Lammertsma A.A.; Scheltens P.; Visser P.J.; Barkhof F.; van Berckel B.N.M.; Assessing Amyloid Pathology in Cognitively Normal Subjects Using F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods. J Nucl Med 2019,60(4),541-547","journal-title":"J Nucl Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2967\/jnumed.114.139121","volume":"55","author":"Zwan M.D.","year":"2014","unstructured":"Zwan M.D.; Ossenkoppele R.; Tolboom N.; Beunders A.J.; Kloet R.W.; Adriaanse S.M.; Boellaard R.; Windhorst A.D.; Raijmakers P.; Adams H.; Lammertsma A.A.; Scheltens P.; van der Flier W.M.; van Berckel B.N.; Comparison of simplified parametric methods for visual interpretation of 11C-Pittsburgh compound-B PET images. J Nucl Med 2014,55(8),1305-1307","journal-title":"J Nucl Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2967\/jnumed.116.188029","volume":"58","author":"Lammertsma A.A.","year":"2017","unstructured":"Lammertsma A.A.; Forward to the Past: The Case for Quantitative PET Imaging. J Nucl Med 2017,58(7),1019-1024","journal-title":"J Nucl Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/jcbfm.1993.6","volume":"13","author":"Carson R.E.","year":"1993","unstructured":"Carson R.E.; Channing M.A.; Blasberg R.G.; Dunn B.B.; Cohen R.M.; Rice K.C.; Herscovitch P.; Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab 1993,13(1),24-42","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.2967\/jnumed.117.200964","volume":"59","author":"Bullich S.","year":"2018","unstructured":"Bullich S.; Barthel H.; Koglin N.; Becker G.A.; De Santi S.; Jovalekic A.; Stephens A.W.; Sabri O.; Validation of Noninvasive Tracer Kinetic Analysis of F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol. J Nucl Med 2018,59(7),1104-1110","journal-title":"J Nucl Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/jnnp-2014-308094","volume":"86","author":"Ong K.T.","year":"2015","unstructured":"Ong K.T.; Villemagne V.L.; Bahar-Fuchs A.; Lamb F.; Langdon N.; Catafau A.M.; Stephens A.W.; Seibyl J.; Dinkelborg L.M.; Reininger C.B.; Putz B.; Rohde B.; Masters C.L.; Rowe C.C.; A\u03b2 imaging with 18F-florbetaben in prodromal Alzheimer\u2019s disease: a prospective outcome study. J Neurol Neurosurg Psychiatry 2015,86(4),431-436","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.2967\/jnumed.116.187351","volume":"58","author":"Bullich S.","year":"2017","unstructured":"Bullich S.; Villemagne V.L.; Catafau A.M.; Jovalekic A.; Koglin N.; Rowe C.C.; De Santi S.; Optimal Reference Region to Measure Longitudinal Amyloid-\u03b2 Change with F-Florbetaben PET. J Nucl Med 2017,58(8),1300-1306","journal-title":"J Nucl Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3174\/ajnr.A4281","volume":"36","author":"Nayate A.P.","year":"2015","unstructured":"Nayate A.P.; Dubroff J.G.; Schmitt J.E.; Nasrallah I.; Kishore R.; Mankoff D.; Pryma D.A.; Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation. AJNR Am J Neuroradiol Alzheimer\u2019s Disease Neuroimaging Initiative2015,36(7),1237-1244","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.nicl.2017.04.025","volume":"15","author":"Bullich S.","year":"2017","unstructured":"Bullich S.; Seibyl J.; Catafau A.M.; Jovalekic A.; Koglin N.; Barthel H.; Sabri O.; De Santi S.; Optimized classification of F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment. Neuroimage Clin 2017,15,325-332","journal-title":"Neuroimage Clin"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jalz.2014.09.004","volume":"11","author":"Schmidt M.E.","year":"2015","unstructured":"Schmidt M.E.; Chiao P.; Klein G.; Matthews D.; Thurfjell L.; Cole P.E.; Margolin R.; Landau S.; Foster N.L.; Mason N.S.; De Santi S.; Suhy J.; Koeppe R.A.; Jagust W.; The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data. Alzheimers Dement Alzheimer\u2019s Disease Neuroimaging Initiative2015,11(9),1050-1068","journal-title":"Alzheimers Dement"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"Thal D.R.","year":"2002","unstructured":"Thal D.R.; R\u00fcb U.; Orantes M.; Braak H.; Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002,58(12),1791-1800","journal-title":"Neurology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/brain\/awq310","volume":"134","author":"Knight W.D.","year":"2011","unstructured":"Knight W.D.; Okello A.A.; Ryan N.S.; Turkheimer F.E.; Rodr\u00edguez Martinez de Llano S.; Edison P.; Douglas J.; Fox N.C.; Brooks D.J.; Rossor M.N.; Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. Brain 2011,134(Pt 1),293-300","journal-title":"Brain"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2967\/jnumed.118.207811","volume":"60","author":"Lilja J.","year":"2019","unstructured":"Lilja J.; Leuzy A.; Chiotis K.; Savitcheva I.; S\u00f6rensen J.; Nordberg A.; Spatial Normalization of F-Flutemetamol PET Images Using an Adaptive Principal-Component Template. J Nucl Med 2019,60(2),285-291","journal-title":"J Nucl Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1088\/0031-9155\/61\/15\/5768","volume":"61","author":"Akamatsu G.","year":"2016","unstructured":"Akamatsu G.; Ikari Y.; Ohnishi A.; Nishida H.; Aita K.; Sasaki M.; Yamamoto Y.; Sasaki M.; Senda M.; Automated PET-only quantification of amyloid deposition with adaptive template and empirically pre-defined ROI. Phys Med Biol 2016,61(15),5768-5780","journal-title":"Phys Med Biol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/mds.27403","volume":"33","author":"Donaghy P.C.","year":"2018","unstructured":"Donaghy P.C.; Firbank M.J.; Thomas A.J.; Lloyd J.; Petrides G.; Barnett N.; Olsen K.; O\u2019Brien J.T.; Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies. Mov Disord 2018,33(7),1130-1138","journal-title":"Mov Disord"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00259-015-2988-7","volume":"42","author":"Hutton C.","year":"2015","unstructured":"Hutton C.; Declerck J.; Mintun M.A.; Pontecorvo M.J.; Devous M.D.; Joshi A.D.; Quantification of 18F-florbetapir PET: comparison of two analysis methods. Eur J Nucl Med Mol Imaging Alzheimer\u2019s Disease Neuroimaging Initiative2015,42(5),725-732","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/JAD-132783","volume":"41","author":"Scheinin N.M.","year":"2014","unstructured":"Scheinin N.M.; Wikman K.; Jula A.; Perola M.; Vahlberg T.; Rokka J.; N\u00e5gren K.; Viitanen M.; Rinne J.O.; Cortical \u00b9\u00b9C-PIB uptake is associated with age, APOE genotype, and gender in \u201chealthy aging\u201d. J Alzheimers Dis 2014,41(1),193-202","journal-title":"J Alzheimers Dis"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","volume":"71","author":"Beach T.G.","year":"2012","unstructured":"Beach T.G.; Monsell S.E.; Phillips L.E.; Kukull W.; Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J Neuropathol Exp Neurol 2012,71(4),266-273","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Current Radiopharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/184323","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184323\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/184323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T05:21:50Z","timestamp":1629177710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184323\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874471013666200729155717","relation":{},"ISSN":["1874-4710"],"issn-type":[{"value":"1874-4710","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-02-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}